Skip to main content
Year archive

CLEVER CULTURE SYSTEMS LIMITED — 2023 filings

All 99 regulatory filings released by CLEVER CULTURE SYSTEMS LIMITED (CC5) in 2023, sourced directly from the official regulator.

99 Filings
2023 Period
2023 filings (99)
Filing Released Lang
Notice of initial substantial holder 4 pages 663.9KB
Major Shareholding Notification
2023-12-21 English
Notice under Section 708A - Cleansing Notice 1 page
Capital/Financing Update
2023-12-21 English
Change of Director's Interest Notice - R Wilson 2 pages 244.8KB
Director's Dealing
2023-12-21 English
Change of Director's Interest Notice - B O'Dwyer 2 pages 245.8KB
Director's Dealing
2023-12-21 English
Notification regarding unquoted securities - LBT 5 pages 26.4KB
Share Issue/Capital Change
2023-12-18 English
Application for quotation of securities - LBT 6 pages 27.9KB
Capital/Financing Update
2023-12-18 English
Application for quotation of securities - LBT 6 pages 27.9KB
Capital/Financing Update
2023-12-18 English
Application for quotation of securities - LBT 6 pages 28.5KB
Share Issue/Capital Change
2023-12-18 English
Initial Director's Interest Notice 2 pages 205.3KB
Director's Dealing
2023-12-18 English
Change of Director's Interest Notice 3 pages 263.2KB
Director's Dealing
2023-12-18 English
Change in substantial holding 2 pages 360.1KB
Major Shareholding Notification
2023-12-18 English
Ceasing to be a substantial holder 2 pages 303.8KB
Major Shareholding Notification
2023-12-14 English
Director Appointment & Company Update 2 pages 141.0KB
Board/Management Information
2023-12-13 English
Notice under Section 708A - Cleansing Notice 1 page
Capital/Financing Update
2023-12-12 English
Notice of change of interests of substantial holder 2 pages 743.5KB
Major Shareholding Notification
2023-12-12 English
Application for quotation of securities - LBT 7 pages 30.9KB
Share Issue/Capital Change
2023-12-10 English
Final Placement Concludes Entitlement Offer 1 page
Capital/Financing Update
2023-12-07 English
Application for quotation of securities - LBT 8 pages 32.6KB
Share Issue/Capital Change
2023-12-07 English
Final Director's Interest Notice 2 pages 196.9KB
Director's Dealing
2023-12-04 English
APAS Presented at Australian Pharmaceutical Conference 1
Regulatory Filings
2023-11-29 English
Chair's Address to Shareholders 3 pages 139.8KB
AGM Information
2023-11-28 English
CEO Presentation 9 pages 1.1MB
Investor Presentation
2023-11-28 English
Results of Meeting 2 pages 192.9KB
Declaration of Voting Results & Voting Rights Announcements
2023-11-28 English
Board Changes and AGM Resolutions Update 1 page 124
Board/Management Information
2023-11-26 English
EU Market Development Initiated for APAS PharmaQC 2 pages 257.6KB
Regulatory Filings
2023-11-22 English
Appendix 3Y - D Lismore 3 pages 184.2KB
Director's Dealing
2023-11-20 English
Appendix 3Y - R Wilson 2 pages 181.1KB
Director's Dealing
2023-11-20 English
Appendix 3Y - B Barnes 3 pages 196.6KB
Director's Dealing
2023-11-20 English
Notice of initial substantial holder 2 pages 83.4KB
Major Shareholding Notification
2023-11-20 English
Notice of ceasing to be a substantial holder 1 page
Major Shareholding Notification
2023-11-20 English
Notice of change of interests of substantial holder 2 pages 350.2KB
Major Shareholding Notification
2023-11-20 English
Notice under Section 708A - Cleansing Notice 1 page
Capital/Financing Update
2023-11-20 English
Placement Completes Financial Restructure 2 pages 143.0KB
Capital/Financing Update
2023-11-19 English
Application for quotation of securities - LBT 8 pages 32.8KB
Capital/Financing Update
2023-11-19 English
Notice of initial substantial holder 2 pages 199.9KB
Major Shareholding Notification
2023-11-19 English
Notice of initial substantial holder 2 pages 227.2KB
Major Shareholding Notification
2023-11-19 English
Notice of initial substantial holder 2 pages 1.7MB
Major Shareholding Notification
2023-11-19 English
Renounceable Rights Issue Results 2 pages 127.4KB
Capital/Financing Update
2023-11-14 English
Application for quotation of securities - LBT 8 pages 33.0KB
Capital/Financing Update
2023-11-14 English
Top 20 Option Holders 5 pages 142.0KB
Major Shareholding Notification
2023-11-14 English
$1.7M SA Government Loan Restructure 2 pages 157.3KB
Capital/Financing Update
2023-11-05 English
Entitlement Offer Underwriting Increased to $3.6M 1
Capital/Financing Update
2023-10-26 English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 480.8KB
Interim / Quarterly Report Q1 2024
2023-10-25 English
Notice of Annual General Meeting/Proxy Form 30 pages 899.7KB
AGM Information
2023-10-24 English
Proposed issue of securities - LBT 5 pages 27.6KB
Capital/Financing Update
2023-10-24 English
Entitlement Offer Letters Mailed to Shareholders 11 pages 478.8KB
Capital/Financing Update
2023-10-22 English
Full Repayment of $1.38M Share Placement Facility 1
Capital/Financing Update
2023-10-12 English
$4.5 million Entitlement Offer 3 pages 166.0KB
Capital/Financing Update
2023-10-12 English
Prospectus 64 pages 838.2KB
Capital/Financing Update
2023-10-12 English
Proposed issue of securities - LBT 10 pages 44.6KB
Capital/Financing Update
2023-10-12 English
Investor Call - Entitlement Offer 1 page 116.8KB
Call Transcript
2023-10-12 English
APAS PharmaQC Exhibited at Pharmaceutical Conference 2 pages 252.6KB
Regulatory Filings
2023-10-04 English
Corporate Governance Statement 11 pages 322.2KB
Governance Information
2023-09-28 English
Appendix 4G 13 pages 347.2KB
Regulatory Filings
2023-09-28 English
Annual Report 86 pages 5.4MB
Annual Report FY 2023
2023-09-28 English
Application for quotation of securities - LBT 6 pages 27.8KB
Share Issue/Capital Change
2023-09-10 English
LBT RECEIVES $848,673 R&D TAX INCENTIVE 1 page 103.
Regulatory Filings
2023-09-04 English
Notice under Section 708A - Cleansing Notice 1 page
Capital/Financing Update
2023-09-03 English
Application for quotation of securities - LBT 6 pages 28.0KB
Share Issue/Capital Change
2023-08-31 English
Preliminary Annual Financial Report & Appendix 4E 47 pages 1.5MB
Annual Report FY 2023
2023-08-30 English
Proposed issue of securities - LBT 5 pages 27.7KB
Capital/Financing Update
2023-08-28 English
Proposed issue of securities - LBT 5 pages 27.4KB
Capital/Financing Update
2023-08-28 English
Application for quotation of securities - LBT 6 pages 27.8KB
Share Issue/Capital Change
2023-08-20 English
First APAS PharmaQC Performance Data 4 pages 504.5KB
Capital/Financing Update
2023-08-09 English
Notice under Section 708A - Cleansing Notice 1 page
Capital/Financing Update
2023-08-06 English
Non-Cash Impairment of Intangible Assets 2 pages 125.6KB
Audit Report / Information FY 2023
2023-08-03 English
Application for quotation of securities - LBT 6 pages 28.0KB
Capital/Financing Update
2023-07-30 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 436.0KB
Interim / Quarterly Report Q4 2023
2023-07-25 English
Notification of cessation of securities - LBT 4 pages 24.0KB
Capital/Financing Update
2023-07-11 English
Notification of cessation of securities - LBT 4 pages 24.0KB
Regulatory Filings
2023-07-09 English
Proposed issue of securities - LBT 6 pages 29.7KB
Capital/Financing Update
2023-07-04 English
Initial Directors Interest Notice 2 pages 157.1KB
Director's Dealing
2023-07-04 English
Final Directors Interest Notice 2 pages 204.8KB
Director's Dealing
2023-07-04 English
Chairman Appointment/Resignation 2 pages 128.8KB
Board/Management Information
2023-07-02 English
APAS Compact Extension to Project Funding Timeframe 2 pages 127.5KB
Capital/Financing Update
2023-06-19 English
APAS Presented at ASM Conference 2 pages 141.9KB
Regulatory Filings
2023-06-19 English
Application for quotation of securities - LBT 6 pages 28.0KB
Share Issue/Capital Change
2023-06-01 English
Notice under Section 708A - Cleansing Notice 1 page
Capital/Financing Update
2023-06-01 English
Application for quotation of securities - LBT 6 pages 28.0KB
Capital/Financing Update
2023-05-25 English
Notice under Section 708A - Cleansing Notice 1 page
Capital/Financing Update
2023-05-25 English
New Company Presentation 16 pages 1.7MB
Investor Presentation
2023-05-11 English
Upcoming Investor Webinar Presentation 1 page 111.7
Investor Presentation
2023-05-09 English
LBT Board - Chair Transition Process 1 page 116.5KB
Board/Management Information
2023-05-07 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 376.5KB
Interim / Quarterly Report Q3 2023
2023-04-27 English
NEW APAS-AMR DATA PRESENTED AT GLOBAL CONFERENCE 2 pages 253.3KB
Regulatory Filings
2023-04-18 English
Notification of cessation of securities - LBT 4 pages 24.3KB
Share Issue/Capital Change
2023-04-10 English
Director Retirement & Appendix 3Z 3 pages 261.0KB
Board/Management Information
2023-03-29 English
Application for quotation of securities - LBT 6 pages 28.3KB
Share Issue/Capital Change
2023-03-22 English
Notification regarding unquoted securities - LBT 7 pages 30.8KB
Capital/Financing Update
2023-03-22 English
Notice under Section 708A - Cleansing Notice 1 page
Capital/Financing Update
2023-03-22 English
Placement Supports APAS Pharma & EU Expansion 3 pages 181.0KB
Capital/Financing Update
2023-03-19 English
Proposed issue of securities - LBT 7 pages 32.9KB
Capital/Financing Update
2023-03-19 English
Half Yearly Report and Accounts 23 pages 1.2MB
Interim / Quarterly Report H1 2023
2023-02-27 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 407.2KB
Interim / Quarterly Report Q2 2023
2023-01-22 English
LBT Company Presentation 14 pages 1.1MB
Investor Presentation
2023-01-19 English
Quarterly Investor Call 1 page 110.5KB
Call Transcript
2023-01-18 English
Notification of cessation of securities - LBT 4 pages 24.4KB
Regulatory Filings
2023-01-10 English
AstraZeneca Partners LBT for APAS Pharma Development 2 pages 123.5KB
Capital/Financing Update
2023-01-08 English
Release from Escrow 1 page 89.7KB
Capital/Financing Update
2023-01-02 English